Lumen (LUMN) Chief Revenue Officer awarded 634,699 restricted shares

Rhea-AI Filing Summary

Sharritts Jeffery S. reported acquisition or exercise transactions in this Form 4 filing.

Lumen Technologies executive Jeffery S. Sharritts, EVP and Chief Revenue Officer, received a grant of 634,699 shares of common stock at no purchase price. The award is restricted stock, with 40% vesting over time and 60% tied to performance metrics through March 1, 2029.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Sharritts Jeffery S.

Role EVP, Chief Revenue Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	634,699	$0.00	--

Holdings After Transaction: Common Stock — 1,210,981 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sharritts Jeffery S.

(Last) (First) (Middle)

100 CENTURYLINK DR

(Street)

MONROE LA 71203

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Lumen Technologies, Inc. [ LUMN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Revenue Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/01/2026		A(1)		634,699	A	$0	1,210,981	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of restricted stock (40% time-based and 60% performance-based). The time-based portion will vest in three equal annual installments beginning on March 1, 2027. Vesting of the performance-based portion is dependent upon the extent to which two three-year performance metrics are achieved, with any earned shares vesting on March 1, 2029.

Remarks:

	/s/ Jennifer Hodges, as Attorney-in-Fact for Jeffery S. Sharritts	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Lumen (LUMN) executive Jeffery Sharritts report on this Form 4?

Jeffery S. Sharritts reported receiving a grant of 634,699 shares of Lumen common stock. The award is restricted stock, given at no purchase price, and is split between time-based and performance-based vesting conditions over multi-year periods.

How many Lumen (LUMN) shares did Jeffery Sharritts acquire in this grant?

He acquired 634,699 shares of Lumen common stock as a restricted stock grant. This award increased his directly held position to 1,210,981 shares following the transaction, according to the reported post-transaction ownership figure on the Form 4.

How does the time-based portion of Jeffery Sharritts’ Lumen (LUMN) award vest?

The time-based 40% portion of the restricted stock will vest in three equal annual installments. These installments begin on March 1, 2027, creating a three-year vesting schedule tied solely to continued service-based conditions for that part of the grant.

What conditions apply to the performance-based part of the Lumen (LUMN) stock grant?

The 60% performance-based portion depends on achieving two three-year performance metrics. Any shares earned under these metrics will vest on March 1, 2029, meaning actual vesting is contingent on performance outcomes over the specified multi-year periods.

What is Jeffery Sharritts’ role at Lumen (LUMN) associated with this stock grant?

Jeffery S. Sharritts serves as Executive Vice President and Chief Revenue Officer at Lumen Technologies. The Form 4 shows this equity grant as part of his compensation, aligning his interests with company performance through time-based and performance-based restricted stock.

Was there any purchase price for the Lumen (LUMN) restricted stock granted to Jeffery Sharritts?

No, the reported transaction price per share was 0.0000, indicating the restricted stock was granted without a cash purchase. Value for Sharritts depends on future vesting of the time-based and performance-based shares and Lumen’s stock price at those times.